EE200400010A - 4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid - Google Patents

4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid

Info

Publication number
EE200400010A
EE200400010A EEP200400010A EEP200400010A EE200400010A EE 200400010 A EE200400010 A EE 200400010A EE P200400010 A EEP200400010 A EE P200400010A EE P200400010 A EEP200400010 A EE P200400010A EE 200400010 A EE200400010 A EE 200400010A
Authority
EE
Estonia
Prior art keywords
hydroxydiphenylmethyl
hydroxybutyl
piperidinyl
hydrochloride
crystalline forms
Prior art date
Application number
EEP200400010A
Other languages
English (en)
Estonian (et)
Inventor
Satyanarayana Reddy M.
Thirumalai Rajan S.
V. Bhaskara Rao U.
Original Assignee
Dr. Reddy's Laboratories Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr. Reddy's Laboratories Ltd. filed Critical Dr. Reddy's Laboratories Ltd.
Publication of EE200400010A publication Critical patent/EE200400010A/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/20Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms
    • C07D211/22Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by singly bound oxygen or sulphur atoms by oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • A61P11/08Bronchodilators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200400010A 2001-06-18 2001-07-31 4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid EE200400010A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN484MA2001 2001-06-18
PCT/US2001/023994 WO2002102777A2 (en) 2001-06-18 2001-07-31 NOVEL CRYSTALLINE FORMS OF 4-[4-[4-(HYDROXYDIPHENYLMETHYL)-1-PIPERINDINYL]-1-HYDROXYBUTYL]-α, α-DIMETHYLBENZENE ACETIC ACID AND ITS HYDROCHLORIDE

Publications (1)

Publication Number Publication Date
EE200400010A true EE200400010A (et) 2004-02-16

Family

ID=34566868

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200400010A EE200400010A (et) 2001-06-18 2001-07-31 4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid

Country Status (20)

Country Link
EP (2) EP1399422A2 (xx)
JP (2) JP2005507374A (xx)
KR (1) KR20040015734A (xx)
CN (1) CN100390145C (xx)
AU (1) AU2001278094B2 (xx)
BG (1) BG108435A (xx)
BR (1) BR0117054A (xx)
CA (2) CA2450858C (xx)
CO (1) CO5540340A2 (xx)
CZ (1) CZ20033358A3 (xx)
EE (1) EE200400010A (xx)
HU (1) HUP0401546A2 (xx)
IL (2) IL159266A0 (xx)
MX (1) MXPA03011728A (xx)
NZ (1) NZ530118A (xx)
PL (1) PL367632A1 (xx)
RU (1) RU2269516C2 (xx)
SK (1) SK15372003A3 (xx)
WO (1) WO2002102777A2 (xx)
ZA (1) ZA200309557B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL158334A0 (en) * 2001-04-09 2004-05-12 Teva Pharma Polymorphs of fexofenadine hydrochloride
US20040044038A1 (en) * 2002-06-10 2004-03-04 Barnaba Krochmal Polymorphic form XVI of fexofenadine hydrochloride
GB0319935D0 (en) 2003-08-26 2003-09-24 Cipla Ltd Polymorphs
KR20070007196A (ko) * 2004-04-26 2007-01-12 테바 파마슈티컬 인더스트리즈 리미티드 펙소페나딘 히드로클로라이드의 결정형 및 이의 제조 방법
ITMI20041143A1 (it) * 2004-06-08 2004-09-08 Dipharma Spa Polimorfi di fexofenadina e procedimento per la loro preparazione
ITMI20041568A1 (it) * 2004-07-30 2004-10-30 Dipharma Spa "polimorfi di fexofenadina base"
JP2008514641A (ja) * 2004-09-28 2008-05-08 テバ ファーマシューティカル インダストリーズ リミティド 結晶形フェキソフェナジン、およびその調製方法
WO2007007347A1 (en) * 2005-07-07 2007-01-18 Wockhardt Limited Industrial process of fexofenadine hydrochloride with controlled side products
US20090306135A1 (en) 2008-03-24 2009-12-10 Mukesh Kumar Sharma Stable amorphous fexofenadine hydrochloride
CN104072402B (zh) * 2014-07-16 2016-08-17 昆山龙灯瑞迪制药有限公司 一种新结晶形式的盐酸非索非那定化合物及其制备方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4254129A (en) 1979-04-10 1981-03-03 Richardson-Merrell Inc. Piperidine derivatives
ES2176329T3 (es) 1994-05-18 2002-12-01 Aventis Pharma Inc Procedimientos para preparar formas anhidras e hidratadas de derivados antihistaminicos de piperidina, sus polimeros y pseudomorfos.
US6153754A (en) * 1995-12-21 2000-11-28 Albany Molecular Research, Inc. Process for production of piperidine derivatives
IN191492B (xx) 1999-05-25 2003-12-06 Ranbaxy Lab Ltd
GB0018691D0 (en) * 2000-07-28 2000-09-20 Rolabo Sl Process

Also Published As

Publication number Publication date
CO5540340A2 (es) 2005-07-29
EP2261209A1 (en) 2010-12-15
CN1518540A (zh) 2004-08-04
IL159266A0 (en) 2004-06-01
CA2450858C (en) 2009-04-07
CA2646802A1 (en) 2002-12-27
CZ20033358A3 (en) 2004-04-14
ZA200309557B (en) 2004-09-14
KR20040015734A (ko) 2004-02-19
WO2002102777A3 (en) 2003-02-27
RU2269516C2 (ru) 2006-02-10
IL159266A (en) 2010-11-30
EP1399422A2 (en) 2004-03-24
PL367632A1 (en) 2005-03-07
BG108435A (en) 2004-12-30
WO2002102777A8 (en) 2003-10-30
JP2005507374A (ja) 2005-03-17
BR0117054A (pt) 2004-07-27
SK15372003A3 (sk) 2004-08-03
WO2002102777A2 (en) 2002-12-27
MXPA03011728A (es) 2004-07-08
RU2004101045A (ru) 2005-06-27
HUP0401546A2 (hu) 2004-12-28
JP2008094848A (ja) 2008-04-24
CA2450858A1 (en) 2002-12-27
NZ530118A (en) 2007-05-31
AU2001278094B2 (en) 2006-01-12
CN100390145C (zh) 2008-05-28

Similar Documents

Publication Publication Date Title
EE200400010A (et) 4-[4-[4-(hüdroksüdifenüülmetüül)-1-piperidinüül]-1-hüdroksübutüül]-a,a-dimetüülben seenäädikhappe ja selle hüdrokloriidi uued kristalsed vormid
LTC1463716I2 (lt) Pirolidino ir piperidino dariniai kaip NK1 antagonistai
NO20013538L (no) Piperidin, tetrahydropyridin og piperazinderivater, deres fremstilling og anvendelse
NO20023319L (no) Substituerte glutarimider og deres anvendelse som inhibitorer av IL-12-produksjonen
DK1397357T3 (da) Polymorfe former af 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoylbenzofuran-5-yl) piperazinhydrochlorid
ATE391716T1 (de) Monohydrochloridsalz von 1-(3-(3-(4- chlorophenyl)propoxy)propyl)-piperidin
NO20026125L (no) Tetrahydropyridin- eller piperidin-heterocykliske derivater
CA2585705A1 (en) Processes for preparing anhydrous and hydrate forms of antihistaminic piperidine derivatives, polymorphs and pseudomorphs thereof
IL238911A0 (en) Polymorphic form of 3-(4-amino-1-oxo-3,1 dihydro-isoindol-2-yl)-piperidine-6,2-dione
IL160060A0 (en) Piperidine derivatives useful as ccr5 antagonists
NO20012858L (no) 4-(Aminometyl)-piperidin benzamider for behandling av gastrointestinale fortyrrelser
DE69809050D1 (de) Gastrokinetische bicyclische benzamide von 3- oder 4-substituierten 4-(aminomethyl)-piperidinderivaten
NO20043239L (no) Piperidinderivater
IL189986A0 (en) Process for producing 1-benzyl-4-[(5,6-dimethoxy-1-indanon)-2-yl]methylpiperidine or hydrochloride thereof
DK1641784T3 (da) 4-(aminomethyl)piperidinbenzamider som 5HT - antagonister
PL325264A1 (en) Novel derivatives of phenyl-alpha,alpha-dimethylacetic acid, method of obtaining such derivatives, method of obtaining a pharmaceutic agent, application of such derivatives and method of obtaining 4-{4-[4-(hydroxydiphenylmethyl)piperidin]-1-hydroxybutyl}-phenyl-alpha,alpha-dimethylacetic acid
NZ598718A (en) Polymorphic forms of manidipine
NZ306319A (en) 1-alkylphenyl substituted 4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-butanol derivatives and medicaments
UA72890C2 (en) A crystalline form of osanetant (variants), a method for the preparation thereof (variants) and a pharmaceutical composition
ITRM20010260A1 (it) Processo per la preparazione della fexofenadina o acido 4 1-idrossi-4-4- (idrossidifenilmetil)-1-piperidinil|-butil|-alfa,alfa-dimetilbenz
IL152570A0 (en) A process for the preparation of 4-[1-hydroxy-4-[4-(hydroxydiphenylmethyl)-1-piperidinyl]-alpha, alpha-di methylbenzeneacetic acid
ATE344244T1 (de) Substituierte 4-phenyl-1-(1-phenyl-cyclohexyl)-1, 2,3,6-tetrahydropyridine
NO20040479L (no) Solvater av lerkanidipinhydroklorid og nye krystallinske former av lerkanidipinhydroklorid.
ATE554068T1 (de) Verfahren zur herstellung von ketoverbindungen
CY1107658T1 (el) Θειϊκο οξυ μονο-[3-({1-[2-(4-φθορο-φαινυλ)-αιθυλ]-πιπεριδιν-4-υλ}-υδροξυ-μεθυλ)-2-μεθοξυ-φαινυλ] εστερας